Literature DB >> 11687234

Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens.

M Schirle1, T Weinschenk, S Stevanović.   

Abstract

The identification of T cell epitopes from immunologically relevant antigens remains a critical step in the development of vaccines and methods for monitoring of T cell responses. This review presents an overview of strategies that employ computer algorithms for the selection of candidate peptides from defined proteins and subsequent verification of their in vivo relevance by experimental approaches. Several computer algorithms are currently being used for epitope prediction of various major histocompatibility complex (MHC) class I and II molecules, based either on the analysis of natural MHC ligands or on the binding properties of synthetic peptides. Moreover, the analysis of proteasomal digests of peptides and whole proteins has led to the development of algorithms for the prediction of proteasomal cleavages. In order to verify the generation of the predicted peptides during antigen processing in vivo as well as their immunogenic potential, several experimental approaches have been pursued in the recent past. Mass spectrometry-based bioanalytical approaches have been used specifically to detect predicted peptides among isolated natural ligands. Other strategies employ various methods for the stimulation of primary T cell responses against the predicted peptides and subsequent testing of the recognition pattern towards target cells that express the antigen.

Mesh:

Substances:

Year:  2001        PMID: 11687234     DOI: 10.1016/s0022-1759(01)00459-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  23 in total

1.  Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.

Authors:  Morten Nielsen; Claus Lundegaard; Peder Worning; Sanne Lise Lauemøller; Kasper Lamberth; Søren Buus; Søren Brunak; Ole Lund
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

2.  Recovery of known T-cell epitopes by computational scanning of a viral genome.

Authors:  Antoine Logean; Didier Rognan
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

Review 3.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

4.  A probabilistic meta-predictor for the MHC class II binding peptides.

Authors:  Oleksiy Karpenko; Lei Huang; Yang Dai
Journal:  Immunogenetics       Date:  2007-12-19       Impact factor: 2.846

5.  Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.

Authors:  B Li; Y Wang; J Chen; H Wu; W Chen
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

6.  H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicity.

Authors:  An Chen; Li Wang; Jingbo Zhang; Liyun Zou; Zhengcai Jia; Wei Zhou; Ying Wan; Yuzhang Wu
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Analysis and prediction of affinity of TAP binding peptides using cascade SVM.

Authors:  Manoj Bhasin; G P S Raghava
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

Review 8.  High throughput T epitope mapping and vaccine development.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Paolo Moretti; Fabrizio Manca
Journal:  J Biomed Biotechnol       Date:  2010-06-15

9.  Optimization algorithms for functional deimmunization of therapeutic proteins.

Authors:  Andrew S Parker; Wei Zheng; Karl E Griswold; Chris Bailey-Kellogg
Journal:  BMC Bioinformatics       Date:  2010-04-09       Impact factor: 3.169

10.  HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.

Authors:  Ting Chen; Xu-Dong Tang; Yin Wan; Ling Chen; Song-Tao Yu; Zhen Xiong; Dian-Chun Fang; Guang-Ping Liang; Shi-Ming Yang
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.